These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38179859)

  • 1. A Facile and General Tandem Oligonucleotide Synthesis Methodology for DNA and RNA.
    Saraya JS; O'Flaherty DK
    Chembiochem; 2024 Mar; 25(6):e202300870. PubMed ID: 38179859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of oligonucleotide N3'-->P5' phosphoramidate/RNA duplexes with capillary gel electrophoresis.
    DeDionisio L; Raible AM; Gryaznov SM
    Electrophoresis; 1998 Jun; 19(8-9):1265-9. PubMed ID: 9694262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
    Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of an oligonucleotide N3'-->P5' phosphoramidate/phosphorothioate chimera with capillary gel electrophoresis.
    DeDionisio LA; Raible AM; Nelson JS
    Electrophoresis; 1998 Nov; 19(16-17):2935-8. PubMed ID: 9870392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonenzymatic RNA-templated Synthesis of N3'→P5' Phosphoramidate DNA.
    O'Flaherty DK; Zhou L; Szostak JW
    Bio Protoc; 2020 Sep; 10(17):e3734. PubMed ID: 33659395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-amino-2',4'-BNA: novel bridged nucleic acids having an N3'-->P5' phosphoramidate linkage.
    Obika S; Onoda M; Morita K; Andoh J; Koizumi M; Imanishi T
    Chem Commun (Camb); 2001 Oct; (19):1992-3. PubMed ID: 12240255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oligodeoxyribonucleotide N3'--> P5' phosphoramidate duplex forms an A-type helix in solution.
    Ding D; Grayaznov SM; Lloyd DH; Chandrasekaran S; Yao S; Ratmeyer L; Pan Y; Wilson WD
    Nucleic Acids Res; 1996 Jan; 24(2):354-60. PubMed ID: 8628662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phosphoramidate substrate analog is a competitive inhibitor of the Tetrahymena group I ribozyme.
    Hanna RL; Gryaznov SM; Doudna JA
    Chem Biol; 2000 Nov; 7(11):845-54. PubMed ID: 11094338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to oligonucleotide N3'-->P5' phosphoramidate building blocks.
    Zielinska D; Pongracz K; Gryaznov S
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):1063-7. PubMed ID: 16248093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
    Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
    Cancer Res; 2003 Oct; 63(19):6187-94. PubMed ID: 14559802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.